VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
The Coca-Cola Company vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
The Coca-Cola Company
KO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into The Coca-Cola Company's moat claims, evidence, and risks.
View KO analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 79 / 100 for The Coca-Cola Company).
- Segment focus: The Coca-Cola Company has 6 segments (39.6% in North America); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: The Coca-Cola Company has 7 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
The Coca-Cola Company
North America
Nonalcoholic ready-to-drink beverages
North America (primarily United States and Canada)
Retailers, foodservice, and consumers
Brand owner and concentrate/syrup producer; system marketing leadership
39.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
The Coca-Cola Company strengths
Novo Nordisk A/S strengths
Segment mix
The Coca-Cola Company segments
Full profile >Europe, Middle East & Africa
Oligopoly
Latin America
Oligopoly
North America
Oligopoly
Asia Pacific
Oligopoly
Global Ventures
Competitive
Bottling Investments
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.